EGFR and colorectal cancer: For instance, berberine combined with gefitinib is currently being evaluated in a clinical trial as a first-line treatment in lung adenocarcinoma patients with EGFR mutations (NCT03486496), while berberine hydrochloride is in a clinical trial for colorectal adenoma prevention in patients with a history of colorectal cancer (NCT03281096).